EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies

Mariana Pires iD, Ana Cristina Rego iD

International Journal of Molecular Sciences · 01.01.2023 · 24 (1) · 778

DOI: 10.3390/ijms24010778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.01.2023. Verfasst von Mariana Pires und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Polo I, 3004-504 Coimbra, Portugal. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

APOE ε4 allele (ApoE4) is the primary genetic risk factor for sporadic Alzheimer’s disease (AD), expressed in 40–65% of all AD patients. ApoE4 has been associated to many pathological processes possibly linked to cognitive impairment, such as amyloid-β (Aβ) and tau pathologies. However, the exact mechanism underlying ApoE4 impact on AD progression is unclear, while no effective therapies are available for this highly debilitating neurodegenerative disorder. This review describes the current knowledge of ApoE4 interaction with mitochondria, causing mitochondrial dysfunction and neurotoxicity, associated with increased mitochondrial Ca2+ and reactive oxygen species (ROS) levels, and it effects on mitochondrial dynamics, namely fusion and fission, and mitophagy. Moreover, ApoE4 translocates to the nucleus, regulating the expression of genes involved in aging, Aβ production, inflammation and apoptosis, potentially linked to AD pathogenesis. Thus, novel therapeutical targets can be envisaged to counteract the effects induced by ApoE4 in AD brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansApolipoprotein E4Amyloid beta-PeptidesMitophagyMitochondria

Stichwörter der Autor:innen

agingdementiagene expressionmitochondrial functionmitochondrial morphologyneuroinflammationtranscription

Substanzen

Apolipoprotein E4Amyloid beta-Peptides

Autor:innen und Institutionen

  • Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Polo I, 3004-504 Coimbra, Portugal.
  • Faculty of Medicine, University of Coimbra, Polo III, 3004-354 Coimbra, Portugal.

ORCID-Profile: Mariana Pires, Ana Cristina Rego

Zitieren

APA

Pires, M., & Rego, A. C. (2023). Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies. International Journal of Molecular Sciences, 24(1), 778. https://doi.org/10.3390/ijms24010778

Vancouver

Pires M, Rego AC. Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies. International Journal of Molecular Sciences. 2023;24(1):778. doi:10.3390/ijms24010778

BibTeX
@article{Pires2023,
  author = {Pires, Mariana and Rego, Ana Cristina},
  title = {Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {1},
  pages = {778},
  doi = {10.3390/ijms24010778}
}
Kostenlos starten →